Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bilha Fischer

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Purinergic Signalling|April 27, 2019
Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytesMolhm Nassir, Uri Arad, Sang-Yong Lee, et al.
Purinergic Signalling|July 22, 2019
Correction to: Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytesMolhm Nassir, Uri Arad, Sang-Yong Lee, et al.
Inorganic Chemistry|June 29, 2019
Aminomethylene-Phosphonate Analogue as a Cu(II) Chelator: Characterization and Application as an Inhibitor of Oxidation Induced by the Cu(II)-Prion Peptide ComplexNatalie Pariente Cohen, Eliana Lo Presti, Simone Dell'Acqua, et al.
Purinergic Signalling|July 19, 2018
A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonistTali Fishman Jacob, Vijay Singh, Mudit Dixit, et al.
Organic & Biomolecular Chemistry|November 14, 2019
Adenine-(methoxy)-ethoxy-P<sub>α,α</sub>-dithio-triphosphate inhibits pathologic calcium pyrophosphate deposition in osteoarthritic human chondrocytesMolhm Nassir, Salahuddin Mirza, Uri Arad, et al.
Journal of Medicinal Chemistry|May 22, 2014
Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffoldYael Nadel, Joanna Lecka, Yocheved Gilad, et al.
Inorganic Chemistry|September 4, 2019
Correction to Aminomethylene-Phosphonate Analogue as a Cu(II) Chelator: Characterization and Application as an Inhibitor of Oxidation Induced by Cu(II)-Prion Peptide ComplexNatalie Pariente Cohen, Eliana Lo Presti, Simone Dell'Acqua, et al.
Drug Development Research|September 11, 2012
Structure Activity Relationships for Derivatives of Adenosine-5'-Triphosphate as Agonists at P(2) Purinoceptors: Heterogeneity Within P(2X) and P(2Y) SubtypesGeoffrey Burnstock, Bilha Fischer, Charles H V Hoyle, et al.
British Journal of Pharmacology|February 22, 2013
8-BuS-ATP derivatives as specific NTPDase1 inhibitorsJoanna Lecka, Irina Gillerman, Michel Fausther, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Purinergic Signalling|April 27, 2019
Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytesMolhm Nassir, Uri Arad, Sang-Yong Lee, et al.
Purinergic Signalling|July 22, 2019
Correction to: Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytesMolhm Nassir, Uri Arad, Sang-Yong Lee, et al.
Inorganic Chemistry|June 29, 2019
Aminomethylene-Phosphonate Analogue as a Cu(II) Chelator: Characterization and Application as an Inhibitor of Oxidation Induced by the Cu(II)-Prion Peptide ComplexNatalie Pariente Cohen, Eliana Lo Presti, Simone Dell'Acqua, et al.
Purinergic Signalling|July 19, 2018
A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonistTali Fishman Jacob, Vijay Singh, Mudit Dixit, et al.
Organic & Biomolecular Chemistry|November 14, 2019
Adenine-(methoxy)-ethoxy-P<sub>α,α</sub>-dithio-triphosphate inhibits pathologic calcium pyrophosphate deposition in osteoarthritic human chondrocytesMolhm Nassir, Salahuddin Mirza, Uri Arad, et al.
Journal of Medicinal Chemistry|May 22, 2014
Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffoldYael Nadel, Joanna Lecka, Yocheved Gilad, et al.
Inorganic Chemistry|September 4, 2019
Correction to Aminomethylene-Phosphonate Analogue as a Cu(II) Chelator: Characterization and Application as an Inhibitor of Oxidation Induced by Cu(II)-Prion Peptide ComplexNatalie Pariente Cohen, Eliana Lo Presti, Simone Dell'Acqua, et al.
Drug Development Research|September 11, 2012
Structure Activity Relationships for Derivatives of Adenosine-5'-Triphosphate as Agonists at P(2) Purinoceptors: Heterogeneity Within P(2X) and P(2Y) SubtypesGeoffrey Burnstock, Bilha Fischer, Charles H V Hoyle, et al.
British Journal of Pharmacology|February 22, 2013
8-BuS-ATP derivatives as specific NTPDase1 inhibitorsJoanna Lecka, Irina Gillerman, Michel Fausther, et al.
Pageof 8